chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MRI of brain showed I had two strokes, one recent and one older; Difficulty walking/limp; Numbness; Stumbling; Weird feeling; Left leg was very weak; Arm weak feels heavy/left arm felt heavy; Episode of vertigo with difficulty walking; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (MRI of brain showed I had two strokes, one recent and one older) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke. Concurrent medical conditions included Penicillin allergy. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 26-Mar-2021, the patient experienced VERTIGO (Episode of vertigo with difficulty walking). On 18-Apr-2021, the patient experienced LIMB DISCOMFORT (Arm weak feels heavy/left arm felt heavy) and MUSCULAR WEAKNESS (Left leg was very weak). On an unknown date, the patient experienced CEREBROVASCULAR ACCIDENT (MRI of brain showed I had two strokes, one recent and one older) (seriousness criterion medically significant), GAIT INABILITY (Difficulty walking/limp), HYPOAESTHESIA (Numbness), GAIT DISTURBANCE (Stumbling) and FEELING ABNORMAL (Weird feeling). The patient was treated with Physical therapy (Prescribed balance exercise) for Vertigo. At the time of the report, CEREBROVASCULAR ACCIDENT (MRI of brain showed I had two strokes, one recent and one older), VERTIGO (Episode of vertigo with difficulty walking), GAIT INABILITY (Difficulty walking/limp), HYPOAESTHESIA (Numbness), LIMB DISCOMFORT (Arm weak feels heavy/left arm felt heavy), GAIT DISTURBANCE (Stumbling), FEELING ABNORMAL (Weird feeling) and MUSCULAR WEAKNESS (Left leg was very weak) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Cardiac monitoring: normal (normal) normal- no AF. On 22-Apr-2021, Echocardiogram: normal (normal) normal. On 22-Apr-2021, Magnetic resonance imaging head: abnormal (abnormal) Showed two strokes. On 22-Apr-2021, Ultrasound Doppler: abnormal (abnormal) Showed two strokes.         Treatment information were not provided. Action taken with mRNA-1273 in response to the event was not applicable.  Company comment Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On Tuesday I was experiencing hot and cold flashes all day and the injection site was sore and warm to the touch. Wednesday I was feeling extremely tired, body aches and hot and cold flashes. Thursday feeling tired and experiencing what I would consider flu like symptoms. Went to the doctor and tested negative for COVID 19 but was til I was having a reaction to the booster.
swollen tongue; Swollen lip and tongue; This spontaneous case was reported by a consumer and describes the occurrence of MOUTH SWELLING (Swollen lip and tongue) and SWOLLEN TONGUE (swollen tongue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MOUTH SWELLING (Swollen lip and tongue). On an unknown date, the patient experienced SWOLLEN TONGUE (swollen tongue). At the time of the report, MOUTH SWELLING (Swollen lip and tongue) and SWOLLEN TONGUE (swollen tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
nausea, headache,102 degree fever, body aches fast heart rate, tremor, weakness, disorientation, couldn't stand colors, TV, audio books, cough, very sore arm, too weak to walk, almost collapsed, swelling in underarms, lumps in neck.  Symptoms started 24 hours after vaccination.  They lasted 24 hours.  But was week and still nauseous the next 24 hours and then mouth and lips broke out in blisters, had migraine headache.    No treatment.  Couldn't drive.
Vaccine expired on 13-Oct-2021 and placed in refrigerator on 29-Oct-2021; Doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and placed in refrigerator on 29-Oct-2021) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and placed in refrigerator on 29-Oct-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and placed in refrigerator on 29-Oct-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   HCP said that there was a confusion between the expiration date printed in the carton and the expiration date when the quick response (QR) code scanned. Vial was stored in the refrigerator on 29-Oct-2021. No temperature excursions was noted and patient did not experience any adverse event.   Treatment medications were not reported.
A rash appeared on both of my forearms about 2-3 days after the vaccine dose. They were red, small bumps and not particularly itchy. I suspect the rash was from the Moderna vaccine but can't say for sure. I used hydrocortisone ointment for a couple of days and that seemed to help. Within a week the rash had gone away.
positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient) and from a Pfizer-sponsored program COVAX US Support. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot no. EN6207; Expiration Date: 31Jul2021), via an unspecified route of administration on 19Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient had first shot of vaccine on 19Mar2021 and on 29Mar2021 tested positive for Covid. Patient asked, is she need to take the second shot or is it safe to take the second shot if she had the Covid. Patient did not have any trouble with the shot, came up with the Covid after the first shot but she do not think that it was the shot. The outcome of the was unknown.  Information on lot/ batch number has been requested.
VACCINE WAS ADMINISTERED AT APPROXIMATELY 4:10PM.  AT APPROXIMATELY 4:15PM PT WAS STANDING NEXT TO HER MOTHER AT COUNTER AND FAINTED.  911 WAS CONTACTED. PT CAME TO AND SEEMED CONFUSED.  I STAYED WITH PT UNTIL  EMS ARRIVED.  PT WAS TAKEN OUT OF PHARMACY BY EMS FOR FURTHER EVALUATION.
While on ride home from office, mother reports unconsciousness with possible momentary shaking, 911 was called by mother.
Migraine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Apr2021 (Lot number: EW0150) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "high bp" (unspecified if ongoing); "PMDD" (unspecified if ongoing); "migraine w/aura," (unspecified if ongoing); "mal de debarquement" (unspecified if ongoing); "Known allergy to penicillin" (unspecified if ongoing); "Known allergy to sulfa" (unspecified if ongoing); "Known allergy to nightshades" (unspecified if ongoing), notes: Known allergy to nightshades. Concomitant medication(s) included: AMLODIPINE; SERTRALINE; NORETHISTERONE. Past drug history included: Known allergy to erythromycin, reaction(s): "Known allergy to erythromycin"; Known allergy to lanolin, reaction(s): "Known allergy to lanolin"; Known allergy to kaolin, reaction(s): "Known allergy to kaolin". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER2613, Location of injection: Arm Right), administration date: 23Mar2021, when the patient was 37 years old, for COVID-19 immunization, reaction(s): "migraine". The following information was reported: MIGRAINE (non-serious) with onset 16Apr2021, outcome "not recovered", described as "Migraine". Therapeutic measures were not taken as a result of migraine. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient device date was 03DEC2021. No follow-up attempts are possible. No further information is expected.
PRODUCT STORAGE ERROR; JANSSEN COVID 19 VACCINE WAS REFROZEN AND ADMINISTERED; This spontaneous report received from a health care professional concerned a 59 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 212A21A expiry: 20-MAY-2022) dose was not reported, administered on 20-DEC-2021 for prophylactic vaccination. Age at time of vaccination 59 years old. No concomitant medications were reported. On 20-DEC-2021, the patient experienced janssen covid 19 vaccine was refrozen and administered. On an unspecified date, the patient experienced product storage error. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the janssen covid 19 vaccine was refrozen and administered and product storage error was not reported. This report was non-serious. This case, from the same reporter is linked to 20220537683, 20220537548, 20220538428, 20220538297, 20220538573, 20220538480, 20220538149, 20220538379, 20220538437, 20220539045, 20220538666, 20220537688, 20220540611, 20220538693, 20220540474, 20220538890, 20220540853, 20220541180, 20220540524, 20220540570, 20220538316, 20220540688, 20220538347, 20220540642, 20220540814, 20220540765, 20220540420, 20220540816 and 20220541085.
"15 yo male with no hx of allergy, PMH,  or problem with the Pfizer vaccine dose #1.   Today, 1 min right after vaccination with the Pfizer, he passed out for few seconds. He had pallor, sweaty with his eyes closed.  He was supported by the nursing staff.  Pt stabilized and released from the vaccination site w/ father."
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 03-AUG-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, 0.5 ml, (lot # K009105, expiration date 21-JAN-2017) (route and dose were not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the first excursion was 24, 34 and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the second excursion was 176, 48 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
left eye tingling and not able to close with Left side mouth not able to close; left eye tingling and not able to close with Left side mouth not able to close; loss of taste of left side of tongue; Bell's palsy symptoms; Cold with light sneezing; Cold with light sneezing; This is a spontaneous report from a contactable consumer (patient). A 35-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8737), dose 2 via an unspecified route of administration, administered in left arm on 06Apr2021 15:00  as 2nd dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EP6955) administered in left arm on 16Mar2021 18:30 for COVID-19 Immunization. Cold with light sneezing developed on 27Apr2021 and Bell's palsy symptoms developed from 28Apr2021 around night before bed (22:45). On 29Apr2021, left eye tingling and not able to close with Left side mouth not able to close and loss of taste of left side of tongue. Doctor diagnosed on 30Apr2021 that it is early stages of Bell's palsy could be due to vaccine or shingles. No symptoms of shingles. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in doctor or other healthcare professional office/clinic visit. The patient received treatment (Bell's Palsy along with Shingles) for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. There is no COVID prior vaccination, no COVID tested post vaccination,  no known allergies. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Information has been received from a RN concerning a 7 year old white male pt who on 10/06/1997 was vaccinated with a first dose of varicella virus vaccine, live. On 04/12/04, the pt developed 5-6 papules on his back, which changed and scabbed and then a few more followed. The ppt had a doctor visit and was given symptomatic tx by the MD. Laboratory tests were not performed. Subsequently, the pt recovered. Additional information is not expected.
mom states pt screamed @ high pitch scream x 12hr followed by hives all over x 2 days;notified MD-was told no need to panic;
pain in her arm; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the right arm, administration date 10Mar2021 15:15 (Lot number: EN6207) at the age of 56 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "dairy allergy" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing); "Sulfa allergy" (unspecified if ongoing); "gallbladder issues" (unspecified if ongoing); "mitral valve prolapse" (unspecified if ongoing). The patient's concomitant medications were not reported. Concomitant medication included: VITAMIN D3. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 10Mar2021 18:15, outcome "unknown", described as "pain in her arm".  Additional information: Additional concomitant medication included: stone blaster - herbs for gallbladder.  No follow-up attempts are possible. No further information is expected.
Swelling and redness at injection site, shortness of breath, treated in ER with nebulizer and steroids
A female reported that she received an injection of 1995-96 formula influenza virus vaccine (manufacturer unknown) and immediately experienced a headache. She recovered. The pt reported undergoing a thyroidectomy in 1966 and reported experiencing "viral inf. attack on my nervous system" in 1984.
Intense itching on left side of left breast that lasted 3 days.  I did not treat it in any way and did not consult  health care  personnel. The symptom disappeared spontaneously and has not returned. In the mid 1970s ,  I had a benign tumor removed  from my left axilla.
Ringing in the right ear (Tinnitus) , loss of hearing in both ears, sound sensitivity in both ears. Prescribed Prednisone by healthcare provider.
Patient received vaccine and walked over to the monitoring room to have a seat. After about 15 minutes, he felt lightheaded and passed out. Patient woke up and was still lightheaded. 911 was called and patient was sent to the ER. Patient is now doing well.
Most of the vaccine ran down my arm. My are felt the cold liquid before the needle was anywhere close to being injected.  The administrator wasn't sure if it was a faulty syringe or his error, but acknowledged that my shirt sleeve was very wet.  He had no idea how much vaccine actually was administed but stated he could not attempt a second injection.. I contacted my physician, SCDHEC, the CDC and was sent in circles.  Noone knew how to handle this error. I travel internationally and am VERY concerned that I do NOT have adequete protection without this second dose and have requested that someone address this; but no one has and all claim that they have no guideance in this particular situation.
First dose presented sweating, a lot of fever, dizziness, muscle pain, loss of memory, loss of balances, walking pain, head pain.
Information has been received from a RN concerning a 23 year old black LPN male pt with asthma who on 01Jun04 was vaccinated IM in the deltoid with a second dose of hep B virus vaccine rHBsAg (yeast) (lot 646157/0529). There was no illness at the time of vaccination. One to two days post vaccination, the pt developed a dry cough, low grade fever and congestion. Unspecified medical attention was sought and no treatment was required. At the time of report it was noted that the symptoms have remained. No product quality complaint was involved. There were nor relevant diagnostic tests or lab data. There were no adverse events following prior vaccinations. Follow up information received from a RN indicated that on 03Jun04, the pt developed a cough, head and chest congestion, fever, shortness of breath, and posterior thoracic pain in his muscles and joints. The outcome was reported as recovered on 14Jun04. No additional information is expected.
Headache - 04/15/2021 - 7:00p Nausea - 04/15/2021 - 8:00p Headache - 04/16/2021 -  7:00a Exhaustion - 04/16/2021 - 9:00a
Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PARAFFIN (VASELINE INTENSIVE CARE [PARAFFIN]) for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle pain). At the time of the report, MYALGIA (Muscle pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medications were reported.   This case was linked to MOD-2021-017966 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up information received on 12-Jul-2021 and updated outcome of the event as resolved.
Did not have a reaction the evening of immunizations. Had a small local reaction the next day and today spread up the thigh to public area. Parent states it was a "rash-like" redness. No other symptoms. Seen in ER
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concomitant therapy and concurrent condition were not provided. On 06-SEP-2016, the patient received a dose of properly stored, expired M-M-R II (strength, dose and frequency were unknown; lot number K012473 and expiration date 26-AUG-2016). Additional information has been requested.
pt recv vax; started w/ several episodes of paleness & cyanosis around lips and eyes; lethargy; responding to stimuli & was sent to hosp;
flu like symptoms; chills; fatigue; body aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jan-2021 and was forwarded to Moderna on 29-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), CHILLS (chills), FATIGUE (fatigue) and MYALGIA (body aches) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), CHILLS (chills), FATIGUE (fatigue) and MYALGIA (body aches). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), CHILLS (chills), FATIGUE (fatigue) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
BP was racing all night with heart flutters, chest tightness, chronic migraine, seizure, cold sweats, fever, joint pain, and throat issues. fatigue
Pt recvd vax on 18SEP90 & devel back pain radiating to chest which worsened.Later, breathing became painful.
This spontaneous report as received from a licensed practical nurse refers to a female patient of unknown age. No information on the patient's concomitant medications, concurrent conditions, pertinent medical history, drug reactions or allergies was reported. On 01-NOV-2016, the patient was vaccinated intramuscularly with an improperly stored dose of PNEUMOVAX 23 injection (lot # L017265 with expiry date on 10-FEB-2017 or lot # L040456 with expiry date on 10-MAY_2017 (it was unspecified which lot # was administered) (dose and anatomical location were not reported). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Redness and swelling at injection site noted 10/17/09 and seen in office 10/19/09. Erythema induration 3 1/2cm with surrounding erythema 7x5cm
Client reported to this office on 8/20/12 with hx of having flu like symptoms with diarrhea which started on 8/16/2012. These symptoms continued and progressed to a full body rash by 8/18. On 8/20/12 when he presented to this office he c/o of having all over muscle aches and continued to have the all over body rash that was red and itchy.
Fever, chills, soreness and swelling at injection site, chest pains (felt like heart attack,) vomiting, diarrhea, felt like I was going to pass out while seated, achy, lethargic, headache-most were on and off for a week after vaccination.